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Introduction
Insulin resistance (IR) has been considered a major contributor to the pathogenesis of chronic oligoovulation or anovulation as well as other metabolic abnormalities in women with polycystic ovary syndrome (PCOS) (Diamanti-Kandarakis and Dunaif, 2012; Rosenfield, 1997) . The genetic contribution of PCOS has been mapped reproducibly by several investigators (Day et al., 2015; Goodarzi et al., 2012; Hayes et al., 2015; Legro et al., 1998; Shi et al., 2012) . Interestingly, similar reproductive and metabolic phenotype characteristics were found in firstdegree male relatives to PCOS females (Legro et al., 2002; Liu et al., 2014; Recabarren et al., 2008a Recabarren et al., , 2008b . It seems that PCOS is a complex trait because of the interaction of genetic and environmental factors (Rosenfield and Ehrmann, 2016) .
Unexplained or idiopathic male factor infertility means no aetiological factor could be found using the common clinical, instrumental or laboratory methods (Cavallini, 2006) . It was considered that about 60-75% of male infertility cases are idiopathic, because the molecular mechanisms underlying the defects remain unknown (Filliponi and Feil, 2009 ). Testicular histopathology of those patients shows various degrees of spermatogenic impairment but fail to identify specific pathogenesis (Nieschlag and Kamischke, 2010) .
Our hypothesis is that some cases of unexplained male infertility could be due to IR, leading to hypogonadism and other metabolic features (Mansour et al., 2013) . The aim of this work was to test the presence of IR in men with unexplained infertility.
Materials and methods

Study population
One hundred and sixty men with idiopathic oligozoospermia participated in this study. The diagnosis of unexplained infertility was established after complete clinical and laboratory examination of the patients by our andrologists. At least two semen analyses 1-4 weeks apart were evaluated (WHO, 2010) . The inclusion criteria were infertile men with sperm count less than 10 × 10 6 /ml; men with normal hormonal profile (FSH = 1-10 mIU/ml and LH = 1.8-12 mIU/ml), normal secondary sexual characters, and normal sexual function were included. Cases with chronic debilitating illness (e.g. cardiac diseases, epilepsy, renal disorders), diabetes mellitus, clinically evident varicocele, persistent pyospermia, abnormal karyotype, and azoospermia factor microdeletion were excluded. The control group included 79 men with proven fertility within the preceding year.
Methods
Fasting blood samples from the study and control groups were taken to measure the following: serum insulin, glucose, total cholesterol, triglycerides, high-density lipoprotein (HDL), low-density lipoprotein (LDL), testosterone, FSH, LH and prolactin.
IR was calculated by inverting the value of insulin sensitivity. Insulin sensitivity was calculated using the quantitative insulin sensitivity check index (QUICKI). It was derived using the inverse of the sum of the logarithms of the fasting insulin and fasting glucose: 1/(log (fasting insulin mIU/l) + log (fasting glucose mg/dl)). This index correlates well with glucose clamp studies (r = 0.78), and is useful for measuring insulin sensitivity. It is the preferred method for certain types of clinical research (Katz et al., 2000) .
Another method to calculate IR is the homeostatic model assessment (HOMA) test (Matthews et al., 1985) . This is calculated by dividing by 405 the result of multiplying fasting serum insulin by fasting blood glucose, i.e. [fasting glucose (mg/dl) × fasting insulin (mIU/l)]/405.
Body weight, height and body mass index (BMI) were measured and calculated.
Clinical trial registration number: NCT 01509482 at clinical trials.gov.
Ethical approval
The Internal Review Board and Ethical Committee of The Egyptian IVF-ET Centre approved the study on 1 January 2012 (reference number 2012-1).
Statistical analysis
Statistical Package for the Social Sciences (SPSS) version 15 (SPSS Inc., USA) was used. The Mann-Whitney test was used to compare quantitative variables that were not normally distributed. Student's t-test was used to compare quantitative variables that were normally distributed. P < 0.05 was considered statistically significant. The sample sizes were calculated using the OpenEpi sample size calculator for unmatched case control studies. We assumed a confidence level of 95%, an 80% power, a 5% hypothetical proportion of controls with exposure and a 95% hypothetical proportion of cases with exposure (http://www.openepi.com/SampleSize/SSCC.htm).
Results
Fasting insulin level was significantly higher in the study group (13.67 ± 10.44 mIU/l) compared with the control group (5.46 ± 3.15 mIU/l), P < 0.0001. Fasting glucose was 95.86 ± 25.22 mg/dl in the study group, compared with 94.41 ± 30.40 mg/dl in the control group, with no significant difference. Using QUICKI, IR was higher in the study group (2.99 ± 0.33) compared with the comparator group (2.61 ± 0.33), P < 0.0001. Using HOMA, IR was higher in the study group (3.07 ± 2.81) compared with the control group (1.25 ± 0.75), P < 0.0001 (Table 1) . Triglycerides were higher in the study group (142.82 ± 105.31 mg/dl) as compared with the comparator group (114.59 ± 61.42 mg/dl), but not significantly different. Total cholesterol was higher in the study group (198.29 ± 37.52 mg/dl) than in the control group (182.45 ± 35.92 mg/dl), P < 0.05. HDL and LDL levels were comparable in both groups with no statistical significance ( Table 1) . FSH levels were higher in the study group (4.71 ± 2.57 mIU/ml) as compared with the control group (3.15 ± 1.92 mIU/ml), P < 0.0001. LH values were higher in the study group (4.98 ± 2.41 mIU/ml) as compared with the controls (3.15 ± 1.12 mIU/ml), P < 0.0001. Testosterone levels were found to be lower in the study group (5.35 ± 3.02 ng/ml) as compared with the control group (6.62 ± 3.51 mIU/ml), with P < 0.001 ( Table 1) . The BMI was 29.79 ± 3.21 in the study group and 29.12 ± 3.75 in the control group. The mean age was not significantly different between the two groups ( Table 1) .
Discussion
This study identified a group of idiopathic infertile men with IR and other metabolic findings similar to features of PCOS. The link between IR and male infertility has not been clearly demonstrated in the literature. It was suggested that insulin-like growth factor-1 (IGF-1) and its derangement may be involved in male infertility associated with low sperm count (Colombo and Naz, 1999) . In the meantime, IR is directly associated with 1GF-1 levels (Friedrich et al., 2012; Sesti et al., 2005) . However, an inverse correlation between IR and male reproductive functions could not be found (Verit et al., 2014) . It has been demonstrated that parents and brothers (Sir-Petermann et al., 2002; Yildiz et al., 2003) and sons (Recabarren et al., 2008b) of PCOS women exhibit IR. The exact mechanism through which IR can affect spermatogenesis has yet to be discovered. A recent study by Calderón et al. (2016) examined the prevalence of male hypogonadism in moderate to severe obesity and its relationship with IR. It was found that free and total testosterone was negatively correlated with IR and low ejaculate volume with higher BMI and excess body weight.
Obesity-associated IR was demonstrated previously (Bloomgarden, 2003; Newgard et al., 2009; Takeno et al., 2016) . In PCOS women, weight loss and changing lifestyle prior to ovulation induction improved the live birth rate . The adverse effect of obesity on semen quality and reproductive hormones was also demonstrated (Hakonsen et al., 2011; Jensen et al., 2004) . Obesity was found to be associated with poor semen quality and altered reproductive hormonal profile. A study on 483 male partners of infertile couples demonstrated that major differences in reproductive hormone levels are associated with increasing body weight, however, only extreme levels of obesity may negatively influence male reproductive potential (Chavarro et al., 2010) . Obesity was found to increase conversion of testosterone to oestradiol, leading to secondary hypogonadism through reproductive axis suppression (Michalakis et al., 2013) . In another study obesity was also found to be associated with increased seminal insulin with concomitant reduced fertility parameters (Leisegang et al., 2014) . It was demonstrated that sons of PCOS women exhibit higher body weight from early infancy, and IR became evident as the subject got older. In this study, the BMI in the unexplained infertility group was higher than the control group, but the difference was not significant. Therefore, the idiopathic infertility problem cannot be solely attributed to increased body fat; it has to be associated with IR.
It has been estimated that at least one abnormal lipid parameter is found in 70% of obese women with PCOS (Legro et al., 2001) , which is most probably due to IR (Robinson et al., 1996) . Insulin and androgens levels in blood may have opposing effects on lipid profiles in PCOS patients (Li et al., 2016) . Brothers of women with PCOS have significantly higher total and LDL cholesterol as well as triglyceride levels, and IR (Sam et al., 2008) . In this study, serum total cholesterol was found to be significantly higher in the study group. HDL, LDL and triglyceride concentrations were comparable in both groups with no significant difference.
Although only men with normal hormonal profile were included, the FSH and LH levels were significantly higher in the study group compared with controls. Increased FSH and LH response to gonadotrophin-releasing hormone (GnRH) analogue (Liu et al., 2014) , and elevated basal levels of FSH and LH with no decrease in testosterone were found in PCOS male relatives. This may be due to alteration in neuro-endocrine gonadotrophin secretion (Torchen et al., 2016 ). In the current study, the total testosterone level was significantly lower in the study group. The cause of the lower testosterone and its relationship to the increased IR has yet to be investigated. It would be of interest to find out whether men with unexplained infertility and IR have first-degree women relatives with PCOS.
Conclusions
In conclusion, IR in men with unexplained infertility can be a possible cause of hypogonadism and idiopathic oligozoospermia as well as other metabolic abnormalities. More research is needed to further confirm this finding and to investigate the value of insulin sensitizing agents in the treatment of these cases of unexplained male factor infertility. Values presented as mean ± SD. BMI = body mass index; NS = not statistically significant. 
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